Dehaier Earns A- Credit Rating Zhongguancun Enterprises Credit Promotion Association

BEIJING, Jan. 28, 2014 (GLOBE NEWSWIRE) -- Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that the Beijing Zhongguancun Enterprises Credit Promotion Association has awarded Dehaier an A- credit rating. This new rating is effective from December 16, 2013 through December 15, 2014.

Mr. Ping Chen, Chairman and Chief Executive Officer of Dehaier Medical stated, "Dehaier's well-established financial profile, including healthy financial statements, steady cash flow, timely payment and low credit risk, contributed to our favorable rating. This is our second consecutive year receiving the A- credit rating from a well-known rating association in Beijing, a testament to our operations, controls and management. We are confident that focusing on our core business strategies and operating with integrity to validate our credit rating will benefit our company and shareholders over the long term."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the implications, if any, of the credit rating described in this press release. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, fulfillment of bids and contracts, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CONTACT: Dehaier Medical Systems Limited Surie Liu +86 10-5166-0080 lius@dehaier.com.cn Dehaier Medical Systems Limited Tina He +86 10-5166-0080 hexw@dehaier.com.cnSource:Dehaier Medical Systems Limited